Literature DB >> 6688177

The role of 5-aminolaevulinate synthase, haem oxygenase and ligand formation in the mechanism of maintenance of cytochrome P-450 concentration in hepatocyte culture.

L J Hockin, A J Paine.   

Abstract

The present work shows that the ability of pyridines e.g. metyrapone, to maintain the cytochrome P-450 concentration in cultured hepatocytes is not due to their ability to alter the 5-aminolaevulinate synthase and haem oxygenase activities of the hepatocytes. Since ligands such as metyrapone will prevent the cobalt-mediated loss of hepatic cytochrome P-450 in rats, the hypothesis that ligand formation is the mechanism of maintenance of the cytochrome in hepatocyte culture was tested. The observation that non-pyridine ligands will maintain the cytochrome P-450 concentration supports this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688177      PMCID: PMC1154299          DOI: 10.1042/bj2100855

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  The synthesis of 1-arylimidazoles, a new class of steroid hydroxylation inhibitors.

Authors:  A L Johnson; J C Kauer; D C Sharma; R I Dorfman
Journal:  J Med Chem       Date:  1969-11       Impact factor: 7.446

2.  Metyrapone interaction with hepatic microsomal cytochrome P-450 from rats treated with phenobarbital.

Authors:  A G Hildebrandt; K C Leibman; R W Estabrook
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

3.  Ligands maintain cytochrome P-450 in liver cell culture by affecting its synthesis and degradation.

Authors:  A J Paine; P Villa
Journal:  Biochem Biophys Res Commun       Date:  1980-11-28       Impact factor: 3.575

4.  Evidence that ligand formation is a mechanism underlying the maintenance of cytochrome P-450 in rat liver cell culture. Potent maintenance by metyrapone.

Authors:  A J Paine; P Villa; L J Hockin
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

5.  Nutrient imbalance causes the loss of cytochrome P-450 in liver cell culture: formulation of culture media which maintain cytochrome P-450 at in vivo concentrations.

Authors:  A J Paine; L J Hockin
Journal:  Biochem Pharmacol       Date:  1980-12-01       Impact factor: 5.858

6.  Apparent lack of correlation between the loss of cytochrome P-450 in hepatic parenchymal cell culture and the stimulation of haem oxygenase activity.

Authors:  A J Paine; R F Legg
Journal:  Biochem Biophys Res Commun       Date:  1978-03-30       Impact factor: 3.575

7.  The effect of cobaltous chloride on liver haem metabolism in the rat. Evidence for inhibition of haem synthesis and for increased haem degradation.

Authors:  F De Matteis; A H Gibbs
Journal:  Ann Clin Res       Date:  1976

8.  Relationship between the ability of nicotinamide to maintain nicotinamide-adenine dinucleotide in rat liver cell culture and its effect on cytochrome P-450.

Authors:  A J Paine; L J Hockin; R F Legg
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

9.  Brain 5-aminolaevulinate synthase. Developmental aspects and evidence for regulatory role.

Authors:  F De Matteis; P Zetterlund; L Wetterberg
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

10.  Metal induction of haem oxygenase without concurrent degradation of cytochrome P-450. Protective effects of compound SKF 525A on the haem protein.

Authors:  G S Drummond; D W Rosenberg; A Kappas
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

View more
  2 in total

Review 1.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

2.  Cimetidine induces hepatic heme oxygenase activity without altering hepatic heme catabolism.

Authors:  J Reichen; C Hoilien; G R Kirshenbaum
Journal:  Experientia       Date:  1986-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.